Evidence map›Paper›PMID 31615872›Full record

ReviewCold Spring Harbor perspectives in medicine2020

Toward Systems Pathology for PTEN Diagnostics.

Nahal Haddadi, Glena Travis, Najah T Nassif, Ann M Simpson, Deborah J Marsh

Open access · bronzeAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cold Spring Harbor perspectives in medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Genes · 2020
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Nahal Haddadi *School of Life Sciences, University of Technology Sydney, Ultimo, New South Wales 2007, Australia.
Glena Travis *School of Life Sciences, University of Technology Sydney, Ultimo, New South Wales 2007, Australia.
Najah T NassifSchool of Life Sciences, University of Technology Sydney, Ultimo, New South Wales 2007, Australia.
Ann M SimpsonSchool of Life Sciences, University of Technology Sydney, Ultimo, New South Wales 2007, Australia.
Deborah J MarshSchool of Life Sciences, University of Technology Sydney, Ultimo, New South Wales 2007, Australia.
University of Technology Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Germline alterations of the tumor suppressor PTEN have been extensively characterized in patients with PTEN hamartoma tumor syndromes, encompassing subsets of Cowden syndrome, Bannayan-Riley-Ruvalcaba syndrome, Proteus and Proteus-like syndromes, as well as autism spectrum disorder. Studies have shown an increase in the risk of developing specific cancer types in the presence of a germline

Indexed as

Autism Spectrum DisorderBiomarkers, TumorGenes, Tumor SuppressorGenetic TestingGerm-Line MutationHamartoma Syndrome, MultipleMolecular Targeted TherapyNeoplasmsPhosphatidylinositol 3-KinasesPTEN PhosphohydrolaseBiomarkers, TumorPhosphatidylinositol 3-KinasesPTEN PhosphohydrolasePTEN protein, human

Identifiers

PMID31615872
PMCPMC7197423
OpenAlexW2981116044

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.